HTR5A and metabolic dysfunction-associated steatotic liver disease: In addition, gut-derived metabolites of 5-HT have been suggested to be associated with the risk of developing NAFLD, and studies in mice suggest a role for the 5-HT receptors in the development of steatosis13,17.